Basic Information
| LncRNA/CircRNA Name | SNHG3 |
| Synonyms | NA |
| Region | GRCh38_1:28505980-28510892 |
| Ensemble | ENSG00000242125 |
| Refseq | NR_002909.1 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | intrahepatic cholangiocarcinoma |
| ICD-0-3 | C22 |
| Methods | Microarray, RT-qPCR |
| Sample | Tissue-based specimens |
| Expression Pattern | up-regulated |
| Function Description | SNHG3 expression levels were significantly increased in ICC tissues compared to the adjacent non-tumor tissues. A high SNHG3 expression level was significantly correlated with shorter OS in ICC patients. |
| Pubmed ID | 31934101 |
| Year | 2019 |
| Title | LncRNA-SNHG3 Is an Independent Prognostic Biomarker of Intrahepatic Cholangiocarcinoma |
External Links
| Links for SNHG3 | GenBank HGNC NONCODE |
| Links for intrahepatic cholangiocarcinoma | OMIM COSMIC |